Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,390 across all filing types
Latest filing 2026-01-26 Major Shareholding Noti…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of major holdings (voting rights) under the German Securities Trading Act (WpHG). It explicitly identifies 'The Capital Group Companies, Inc.' as the entity subject to the notification obligation regarding its stake in 'Fresenius SE & Co. KGaA'. This matches the definition for a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing regulatory thresholds.
2026-01-26 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of major holdings (voting rights) filed by BlackRock, Inc. regarding Fresenius SE & Co. KGaA. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act) and provides detailed tables of voting rights, instruments, and the chain of controlled undertakings. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2025-11-17 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a formal 'Notification of Major Holdings' regarding BlackRock, Inc.'s shareholding in Fresenius SE & Co. KGaA. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act), which is the standard regulatory requirement for disclosing significant changes in voting rights (major shareholding notifications). This fits the definition of a Major Shareholding Notification (MRQ).
2025-11-14 English
Report Publication Announcement 2025
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Fresenius SE & Co. KGaA that provides a schedule for the future publication of quarterly financial reports. It explicitly states it is a 'Preliminary announcement of the publication of quarterly reports' and provides dates and links for when these reports will be available. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, making it a Report Publication Announcement (RPA).
2025-11-06 English
Q3 statement / Q3 financial report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'QUARTERLY FINANCIAL REPORT' for Q3 2025. It contains comprehensive financial data, including consolidated financial statements, results of operations, segment reporting, and management discussion and analysis. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-11-06 English
Conference Call Q2 Results 2025, Fresenius
Investor Presentation Classification · 1% confidence The document is a detailed slide deck titled 'Q2 2025 results Conference call and webcast for investors and analysts' for Fresenius. It contains financial highlights, business strategy updates, segment performance (Kabi, Helios), and forward-looking guidance. As it is a comprehensive presentation used during an investor conference call to explain financial results and strategy, it is classified as an Investor Presentation.
2025-08-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.